Argus Research Initiates Coverage On 10x Genomics with Buy Rating, Announces Price Target of $110

Benzinga Newsdesk www.benzinga.com Neutral 54.5%

Neg 0% Neu 54.5% Pos 0%

Argus Research analyst John Eade initiates coverage on 10x Genomics (NASDAQ:TXG) with a Buy rating and announces Price Target of $110.